On an SBA file the feasibility study is a credit input the lender may or may not order. On a HUD file it is a gate. Why the agency reviews the market study itself, why it forces the appraisal and the study into different firms on new construction, and why Section 232 was deliberately left out of the MIP cut that reshaped everything else.
There is a structural difference between how the three federal credit programmes treat third-party market analysis, and it is not a difference of degree.
Under the Small Business Administration's current standard operating procedure, a feasibility study is not mandated. The only regulatory basis is permissive, stating that the agency may require one (1), and the procedure delegates the decision to the lender or certified development company. In practice a study is expected on start-ups, ground-up construction, special-purpose collateral and changes of ownership, but the expectation is a credit convention rather than a rule, and a lender that forms a view without one has not violated anything.
The Department of Agriculture sits at the other pole. Its guaranteed lending regulation requires an independent feasibility study prepared by an independent qualified consultant for business and industry guaranteed loans above $1,000,000 to a new business, prescribes its content across five dimensions and enumerates 37 specific factors in an appendix, and reviews it at agency level (2).
The Department of Housing and Urban Development does something different again, and it is the arrangement least understood by borrowers arriving from the small business programmes. For the risk-bearing routes under its multifamily and healthcare mortgage insurance programmes, an independent third-party market study is mandatory, its scope is standardised by handbook, the agency reviews it rather than the lender, and it is a condition of insurance rather than an input to a credit decision.
That last distinction is the one that changes behaviour. On an SBA file, a study that reaches an unhelpful conclusion is evidence a lender weighs against everything else it knows. On a HUD file, a market study that does not support the rents or the absorption does not get outvoted. The deal is resized to what the study supports, delayed until a defensible study exists, or it does not proceed.
This article sets out what HUD actually requires, how the requirement differs between the multifamily and healthcare programmes, and what changed in the last eighteen months that materially alters the arithmetic.
What Chapter 7 requires
The governing document is the Multifamily Accelerated Processing Guide, HUD Handbook 4430.G, in its 2020 edition as revised in March 2021 (3). No final replacement edition has been published, though a draft mortgagee letter dated February 2026 proposing efficiency changes to the market analysis chapter has been circulated for comment and is not in effect (4). Market analysis is governed by Chapter 7, which the handbook titles as covering valuation and market analysis together, and that pairing is itself significant: HUD treats the two as a linked pair of documents rather than as an appraisal with a supporting exhibit.
The required study is a narrative, self-contained third-party report. Its core elements are consistent across the handbook and HUD's own training material (3)(5):
A defined primary market area, with a map and a written justification for the boundaries drawn. A secondary market area where the project draws beyond the primary. This is the element HUD reviewers most frequently challenge, because a boundary drawn to include favourable demographics and exclude competitive supply changes every conclusion downstream of it.
A competitive supply survey, enumerating the comparable properties in the market area with their rents, occupancies, unit mixes, amenities and concessions, gathered by inspection and direct contact rather than from a database.
Capture and penetration analysis, establishing what share of qualified demand the subject must capture to achieve its projected occupancy, and testing whether that share is plausible against the competitive set.
An absorption conclusion, expressed as the period required to reach balanced-market occupancy, which the handbook defines as 95 percent, meaning a 5 percent vacancy (6). That definition matters because absorption to 95 percent is a longer period than absorption to break-even, and a study that quietly measures the shorter period is reporting a different number than HUD asked for.
A rent conclusion, independently derived by the analyst rather than adopted from the developer's pro forma or the appraiser's work.
The analyst's certification, including the independence attestation discussed below.
Who may prepare it, and the rule that surprises people
HUD does not maintain an approved list of market analysts. The lender selects the analyst and is responsible for vetting the selection, and HUD reserves the right to reject the report (3). The qualification floor is a minimum of three years performing market analysis for income-producing property, active current engagement in that work, demonstrated knowledge of the local market, and experience with projects of comparable complexity (3).
The independence requirement is stricter than most borrowers anticipate. The analyst must be independent of the loan originator, the mortgage broker, the developer, the borrower, the lender and any other party holding a financial role in the transaction, and the lender's underwriter may not act as the analyst (3). This is not a disclosure obligation. It is a disqualification.
Then comes the provision that reorders how a sponsor procures third-party reports.
For new construction, for substantial rehabilitation involving tenant displacement, and for low income housing tax credit transactions outside project-based rental assistance, the appraisal and the market study must be prepared by different firms (3). A regional or hub director may waive the requirement case by case, but the default is separation.
The logic is worth stating plainly because it goes to the heart of why the market study functions as a gate. An appraisal establishes value, and value is a function of the income the property is expected to produce. If the same firm produces both the demand analysis and the valuation that depends on it, the demand analysis has an outcome to reach. Separating them forces the valuation to be built on a demand conclusion the valuer did not author and cannot adjust.
The consequence for practice is direct: a sponsor cannot solve a thin market by finding a generous appraiser, because the appraiser is working from someone else's rent and absorption conclusions. And it means the two reports must be procured as two engagements from two firms, on a schedule that allows the market study to inform the appraisal rather than run alongside it.
Where the two documents are allowed to disagree
HUD does not require the market study and the appraisal to reach identical conclusions, which is a point of confusion in origination.
The handbook's structure has the analyst's projected rents compared against the appraiser's independent analysis, with the reconciliation performed by the lender (5). Neither document automatically governs. The lender carries the reconciliation duty, and the reconciliation is itself subject to HUD review.
That arrangement has a practical implication for sponsors and for the firms preparing either report. A material divergence is not a defect to be negotiated away before delivery. It is information, and the reconciliation is where the underwriting judgment actually happens. Where the analyst concludes achievable rents 8 percent below the appraiser's, the correct response is not to average them or to ask one party to revise. It is to identify which comparable set, which adjustment or which market area assumption produces the gap, and to document why the reconciled figure is the defensible one.
Where the divergence is on absorption rather than rent, the stakes are higher, because absorption drives the size of the initial operating deficit escrow and the length of the interest carry rather than merely the value.
The dating windows
Two windows govern how long a report remains usable, and they differ by stage. The effective date of the market study and the appraisal must fall within 120 days before pre-application submission, and within 180 days before the firm commitment (7).
On a transaction that spends time in entitlement, in a two-stage market rate process, or in a queue lengthened by the conditions described later in this article, those windows expire. The remedy is generally an update rather than a new report, but the update has to be performed by the original analyst, and the analyst has to be available and willing to re-certify. A sponsor that commissioned a study early to support an equity raise, then took nine months to reach pre-application, may find the update costs more than the discipline of ordering later would have.
Section 221(d)(4): what the study has to support
The multifamily new construction and substantial rehabilitation programme is where most sponsors first encounter the requirement.
Current underwriting thresholds were reset by mortgagee letter in January 2025 (8). Market rate transactions now support 87 percent of loan to cost at a minimum 1.15 debt service coverage ratio, underwritten at a 7 percent vacancy. Transactions with a low income housing tax credit advantage support 90 percent of cost at 1.11 coverage and a 5 percent vacancy. Transactions with rental assistance covering at least 90 percent of units support 90 percent of cost at 1.11 coverage and a 3 percent vacancy (8).
Those thresholds are the reason the market study matters so much on this programme. At 87 to 90 percent of cost, the loan is sized off the projected net operating income with very little equity cushion beneath it, so an error in the rent conclusion transmits almost directly into an over-levered loan. The vacancy factor prescribed for each category is not a market observation; it is an underwriting floor, and where the market study concludes a stabilised vacancy above the prescribed figure, the higher number governs.
The remaining programme mechanics that a feasibility conclusion has to accommodate:
Term and structure. Up to 40 years fully amortising, plus an interest-only construction period of up to 36 months, giving a maximum of 43 years. Non-recourse and assumable (9).
Eligibility. Five units minimum. Substantial rehabilitation qualifies where repairs exceed roughly $15,000 per unit on a high-cost-adjusted basis, or where two or more major building components are replaced (10).
Escrows. A working capital escrow of 4 percent of the loan for new construction and 2 percent for substantial rehabilitation. An initial operating deficit escrow of at least 3 percent of the loan, refundable. A replacement reserve set at the greater of 0.60 percent of total cost for new construction or 0.40 percent of the loan for rehabilitation, or $250 per unit per year (11)(12).
Builder and sponsor profit and risk allowance. Where the sponsor has an identity of interest with the general contractor, an allowance calculated at 10 percent of mortgageable costs exclusive of land is added into the cost basis, increasing loan proceeds and correspondingly reducing the equity requirement (13). It is a non-cash entry, and a feasibility study modelling sources and uses on a sponsor-builder transaction that omits it will overstate the equity gap materially.
Prevailing wage. Davis-Bacon wage determinations apply to new construction and substantial rehabilitation (11), and the cost consequence in markets where prevailing rates exceed open-shop rates is a hard cost line that has no analogue in a conventionally financed comparable. A cost build-up borrowing from a non-HUD comparable will understate.
Cost certification. Both the general contractor and the owner certify actual costs at completion, and the final insured amount can be reduced if actual costs come in below the underwritten figure.
The premium change that reshaped the economics
The most consequential recent development on the multifamily side is not an underwriting rule. It is the mortgage insurance premium.
Effective for applications submitted or amended on or after 1 October 2025, HUD set the premium at a flat 0.25 percent upfront and 0.25 percent annually across all multifamily housing programmes, replacing a tiered structure that had charged 0.65 percent for market rate transactions, 0.45 percent for affordable, and 0.70 percent under one section, and eliminating the separate green and affordable incentive categories entirely (14).
The agency's own justification for the change contains the more interesting finding. In the notice, HUD reported that between March 2024 and March 2025, 96 percent of loan closings under the two principal multifamily sections used one of the reduced premium incentive categories, and only 4 percent were market rate properties qualifying for neither the green nor the affordable incentive (14).
Read as market intelligence rather than as policy justification, that figure says the incentive structure had stopped discriminating. A premium reduction earned by 96 percent of transactions is not an incentive; it is the standard rate with paperwork attached. Flattening it to 0.25 percent for everyone lowered the all-in cost for the 4 percent, removed a compliance exercise for the 96 percent, and eliminated the green certification premium as a financing advantage.
For a feasibility study, the practical instruction is narrow but real. A projection built on a comparable transaction closed before October 2025 carries a premium assumption that is now wrong, and on a 40-year amortisation the difference between 0.65 percent and 0.25 percent annually is a material coverage item. And any project underwritten partly on the strength of a green certification's financing benefit needs that benefit removed from the analysis, because it no longer exists.
Section 232: three routes, two of which need a study
The healthcare mortgage insurance programme operates on a different track with a different reviewing office, and the market study requirement varies by route.
Section 232 new construction and substantial rehabilitation is the full-underwriting route and requires a market study.
Section 232 pursuant to Section 223(f), covering acquisition or refinance of an existing facility, also requires a market study.
Section 232 pursuant to Section 223(a)(7), a streamlined refinance of a loan HUD already insures, requires neither a new market study nor a new appraisal. The agency is refinancing an exposure it already holds, and the streamlining is the point of the route.
Eligible facilities are skilled nursing, intermediate care, assisted living, board and care and memory care, with a minimum of 20 beds, state licensure, continuous care and three meals daily (15). Two composition limits govern what else can sit inside the project: independent living units are capped at 25 percent of the total, and commercial space and non-resident day care may not exceed 20 percent of floor area or 20 percent of income each (15)(16).
Those limits are a frequent source of failed applications on continuing care projects, and they are a question a market study should answer before design is finalised rather than after. A project that pencils on a 35 percent independent living component is not a Section 232 project, and discovering that at firm application is expensive.
Underwriting thresholds by facility type: 80 percent loan to value for skilled nursing, rising to 85 percent for non-profit sponsors, and 75 percent for assisted living, memory care and board and care, rising to 80 percent for non-profits (15)(17). New construction supports up to 90 percent of replacement cost (18). The minimum debt service coverage ratio is 1.45 times, and it applies both to new construction and to the 223(f) route (16), which is a point worth stating explicitly because the assumption that an acquisition route carries a lower coverage floor is common and, on the available guidance, wrong.
Term runs up to 40 years for new construction, and for 223(f) the lesser of 35 years or 75 percent of remaining economic life (16).
Processing runs through a workflow the department introduced in 2008 and reviews through its residential care facilities office (19), which is organisationally distinct from the multifamily production offices that administer the accelerated processing programme. A sponsor with experience on the multifamily side should not assume the two behave alike.
What a Section 232 market study has to prove that a multifamily study does not
Three analytical problems are specific to the healthcare programme and a study that treats a nursing facility as a specialised apartment building will fail on all three.
The operator is part of the collateral. These transactions require a licensed operator, and the operating structure is typically a lease from the property owner to that operator. The market study is therefore analysing a market for a service delivered by a specific operator with a specific licence, quality history and referral network, not a market for units. An operator change is a market event.
Payor mix is the revenue structure. Revenue per resident day varies enormously by payor, and a facility's mix between private pay, Medicaid, Medicare and managed care determines both the revenue level and its durability. A market study that reports average market rates without addressing the payor composition of demand in the area has not described the revenue the projection depends on, and reimbursement policy risk sits on top of ordinary market risk in a way it does not in multifamily.
Certificate of need can be dispositive. In states operating certificate of need regimes, a facility cannot add licensed beds without state approval, which simultaneously constrains competitive supply, a favourable fact, and constrains the subject, a potentially fatal one. A study in a certificate of need state that does not establish the subject's approval status and the pipeline of approved but unbuilt beds has left the supply analysis undone.
The premium exclusion nobody mentions
The flat 0.25 percent premium described earlier applies to the multifamily programmes. It does not apply to the healthcare programmes.
The January 2025 mortgagee letter states expressly that it is not applicable to the healthcare programmes administered by the office of healthcare programmes (8), and the September 2025 premium notice likewise applies to multifamily housing programmes. Section 232 accordingly remains on its own premium schedule: 1.00 percent upfront, with annual premiums running from 0.55 percent on the streamlined refinance route to 0.77 percent on non-tax-credit transactions, with reduced rates for tax credit and green-qualified projects (16)(20).
The comparison is stark and belongs in any advisory conversation. An apartment project and a skilled nursing facility applying in the same month now pay 0.25 percent and 0.77 percent annually respectively. On a $20 million loan that is a difference of $104,000 a year, which at a 1.45 coverage requirement consumes roughly $150,000 of required net operating income. Section 232 kept the green premium reduction that multifamily lost, so on the healthcare side a green certification remains a live financing advantage rather than a compliance exercise, which is the reverse of the multifamily position.
Timeline, cost, and the 2026 queue
The sequence runs: concept meeting, pre-application, firm application, firm commitment, initial endorsement and closing which starts construction, the construction period itself, and final endorsement at which amortisation begins.
Realistic elapsed time on the multifamily side runs approximately six to ten months from engagement to initial closing, extending past twelve months on market rate transactions using the two-stage process (21). The healthcare side, running through the separate processing workflow, has historically run approximately four to six months from application to closing (16).
Costs a sponsor should budget: a third-party report package and lender application fee of roughly $25,000, covering the appraisal, the market study, the environmental assessment, the construction cost review and the plans review; a HUD examination fee of 0.30 percent of the mortgage, split evenly between pre-application and firm application; an inspection fee of 0.50 percent; a good faith deposit of 0.50 to 1 percent at commitment, refunded at closing; and a financing and placement fee capped at 3.50 percent (12)(9).
The 2026 queue is the variable a projection cannot control. A federal funding lapse beginning 1 October 2025 ran 43 days, with roughly 71 percent of the department's staff furloughed under the contingency plan adopted immediately beforehand, creating a closing backlog (22). Practitioner commentary during the lapse noted that the department was already operating with substantially reduced staffing before it began, and that each additional day of the lapse compounded the processing impact disproportionately (22). On the healthcare side, closing attorney assignment ran as long as 45 days, with lenders expecting the queue to normalise back toward 30 to 60 days (23).
For a feasibility study, the instruction is to model the closing date as a range rather than a point, and to size the interest carry and the initial operating deficit escrow against the long end of the range rather than the sponsor's expectation.
Volume, and what it says about the cycle
Production data confirms the countercyclical pattern that makes these programmes worth understanding.
On the multifamily side, the new construction programme insured 105 projects comprising 17,434 units and $2.5 billion in the 2024 fiscal year (24). Analysis of firm commitment data for the 2025 fiscal year puts the new construction programme at $5.2 billion across 157 loans and the acquisition and refinance programme at $7.1 billion across 309 loans (25).
The healthcare programme had a record year. The department reported $8.1 billion in firm commitments for Section 232 in the 2025 fiscal year, with $6 billion closed across 337 loans, nearly double the prior year's $4.1 billion, and the application backlog falling from 130 at the start of the year to 29 at its end (26).
A record production year running into a 43-day funding lapse is an unusual combination, and it explains why the constraint in 2026 is administrative rather than economic. Current pricing supports the demand: the multifamily new construction programme was quoting from approximately 6.09 percent in late 2025 on a 40-year fixed basis inclusive of the premium (27), and the healthcare programme has priced in a range from approximately 3.10 to 6.45 percent across the 2020 to 2025 period (20). Against conventional and agency alternatives typically capped at 70 to 75 percent of cost, the 87 to 90 percent leverage available here is the reason sponsors accept the process (28).
The department does not publish an application rejection or withdrawal rate, and any figure presented as one is a lender construction rather than an agency statistic.
What happens when the study does not support the deal
This is the question that distinguishes the programme, and the answer is that the sponsor has three outcomes and no fourth.
The deal is resized. Where the study supports lower rents or slower absorption than the pro forma assumed, the loan is sized to the study's conclusions. At 87 to 90 percent of cost, a 5 percent reduction in supportable net operating income translates into a proportionate reduction in loan proceeds and an equivalent increase in the equity requirement, which on a $30 million project is roughly $1.5 million of additional equity that has to come from somewhere.
The deal is delayed. Where the sponsor believes the study is wrong, the remedy is a better study, not an argument. That means a new engagement, a new effective date, and the schedule consequences that follow.
The deal does not proceed. Where the market genuinely does not support the project at a cost that has already been incurred in land and design, the study has done its job at a fraction of the cost of finding out later.
There is no fourth outcome in which the lender proceeds on its own credit judgment, because the study is a condition of insurance rather than a credit input. That is the whole of the difference from the small business programmes.
The three programmes side by side
| Dimension | HUD 221(d)(4) and 232 | SBA 7(a) and 504 | USDA guaranteed |
|---|---|---|---|
| Is a study required | Yes, for the risk-bearing routes | No, risk-based and discretionary | Yes, above the regulatory threshold for new businesses |
| Who mandates it | HUD, by handbook | Lender or CDC judgment; only a permissive regulatory basis | Regulation |
| Who reviews it | The agency | The lender | The agency |
| Who may prepare it | Independent third party, no financial interest, separate firm from the appraiser on new construction and tax credit deals | No named credential or independence standard in the procedure | Independent qualified consultant, no financial interest |
| Prescribed content | Yes: market area, competitive supply, capture and penetration, absorption, rents, certification | No fixed content list | Yes: five dimensions and 37 enumerated factors |
| If the conclusion is negative | Deal resized, delayed or dead; it is a condition of insurance | A credit input the lender may weigh against other factors | Can derail the guarantee |
What a reviewer checks
| Test | What a deficient study shows | What a defensible study shows |
|---|---|---|
| Market area | Boundary asserted | Boundary mapped and justified, with the reasoning for inclusions and exclusions stated |
| Competitive supply | Database extract | Properties surveyed by inspection and direct contact, with rents, occupancies, concessions and unit mix |
| Capture | Demand estimated | Required capture rate computed and tested for plausibility against the competitive set |
| Absorption | Period asserted | Period to 95 percent occupancy derived, with the monthly path shown |
| Rents | Adopted from the pro forma or the appraisal | Independently derived by the analyst, then reconciled |
| Independence | Not addressed | Certification of independence from every party with a financial role, and separate firms where the rule requires it |
| Dating | Report dated whenever prepared | Effective date inside the 120-day pre-application or 180-day firm commitment window, with the update path identified |
| Premium assumption | Carried from a pre-October 2025 comparable | Current premium applied, with the green certification advantage removed on multifamily and retained on healthcare |
| Payor mix, Section 232 | Average market rates | Demand analysed by payor, with reimbursement risk addressed |
| Certificate of need | Not addressed | Subject approval status and the approved but unbuilt pipeline established |
For the cross-asset framework, demand regimes, valuation methods and reviewer tests, see the 2026 Feasibility Methodology Atlas.
Sources
- 13 CFR 120.160(b), permitting but not requiring the Small Business Administration to require a feasibility study, and SOP 50 10 8, effective 1 June 2025 with technical updates effective 1 March 2026, delegating the decision to lender and certified development company judgment.
- 7 CFR Part 5001, the OneRD guaranteed loan regulation effective July 2020, requiring an independent feasibility study by an independent qualified consultant above the regulatory threshold for new businesses, prescribing five feasibility dimensions and enumerating 37 factors in the appendix to the relevant subpart.
- US Department of Housing and Urban Development, Multifamily Accelerated Processing Guide, Handbook 4430.G, 2020 edition as revised 19 March 2021, Chapter 7, on required market study content, analyst qualifications, independence, the separate-firm rule and HUD's right of rejection.
- US Department of Housing and Urban Development, draft mortgagee letter on multifamily improvements for processing efficiency, drafting table copy circulated for public comment, 26 February 2026, proposing changes to the market analysis chapter. Not in effect.
- US Department of Housing and Urban Development, MAP Guide briefing session materials, on the comparison of the analyst's rent conclusions with the appraiser's independent analysis and the lender's reconciliation duty.
- Multifamily Accelerated Processing Guide, Chapter 7, defining absorption as the period to reach balanced-market occupancy of 95 percent.
- Market study and appraisal effective date windows of 120 days before pre-application and 180 days before firm commitment.
- US Department of Housing and Urban Development, Mortgagee Letter 2025-03, 8 January 2025, revising loan to cost, debt service coverage and vacancy thresholds for Section 221(d)(4), and stating that it does not apply to the healthcare programmes administered by the office of healthcare programmes.
- Programme terms for Section 221(d)(4), including amortisation, construction period, non-recourse and assumability, and fee structure, as compiled by programme lenders.
- Substantial rehabilitation qualification threshold for Section 221(d)(4).
- Working capital escrow, initial operating deficit escrow and Davis-Bacon applicability for Section 221(d)(4), as compiled by programme lenders.
- Replacement reserve requirements and HUD examination, inspection, good faith deposit and placement fee structure.
- Builder and sponsor profit and risk allowance calculation and its effect on loan proceeds and equity requirement.
- Federal Register, Changes in Mortgage Insurance Premiums Applicable to FHA Multifamily Insurance Programs, published 23 September 2025, effective for applications submitted or amended on or after 1 October 2025, setting a flat 0.25 percent premium and reporting that 96 percent of closings in the preceding year used a reduced incentive category against 4 percent at the full market rate.
- US Department of Housing and Urban Development, Section 232 Handbook, general programme requirements, on eligible facility types, minimum bed count, licensure and composition limits.
- Section 232 terms including loan to value by facility type, minimum debt service coverage of 1.45 times for new construction and the acquisition and refinance route, term limits, and mortgage insurance premium schedule, as compiled by programme lenders.
- Non-profit sponsor loan to value adjustments under Section 232.
- Section 232 new construction loan to replacement cost limit.
- US Department of Housing and Urban Development, Office of Residential Care Facilities, on the processing workflow introduced in 2008 and the office's review responsibility.
- Section 232 interest rate range across the 2020 to 2025 period and current premium schedule, as compiled by programme lenders.
- Processing timelines from engagement to initial closing on the multifamily side, as reported by programme lenders.
- Federal funding lapse beginning 1 October 2025 running 43 days, staffing furlough under the contingency plan adopted 29 September 2025, and practitioner commentary on the compounding processing impact, as reported in the trade press, October 2025.
- Closing attorney assignment timelines and expected queue normalisation on the healthcare side, as reported in the trade press, December 2025.
- US Department of Housing and Urban Development, descriptions of multifamily programmes, Section 221(d)(4) production for the 2024 fiscal year.
- Analysis of HUD firm commitment data for the 2025 fiscal year, Section 221(d)(4) and Section 223(f) volume and loan counts.
- US Department of Housing and Urban Development and Federal Housing Administration Section 232 production for the 2025 fiscal year, including firm commitments, closed volume, loan count and backlog reduction, as reported in the trade press, November 2025.
- Section 221(d)(4) indicative pricing, November 2025.
- Comparative leverage between HUD-insured and agency, bank and life company alternatives.
Looking for a lender-grade industry guides feasibility study?
Related feasibility study engagements
508-Unit Class A Multifamily Community, Stanislaus County, California
Conventional feasibility study supporting a multifamily project in Stanislaus County.
240-Unit Workforce Multifamily Development, Bexar County, Texas
Conventional feasibility study supporting a multifamily project in Bexar County.
Robert Mitchell, MAI, SRA, AI-GRS
Certified commercial real estate appraiser with extensive experience in industry guides property valuations across the United States.
View team credentials →